ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Oxandrolone with 10mg DHEA at the end: blood tests and my experience
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Rock H. Johnson" data-source="post: 174155" data-attributes="member: 39049"><p>■ The synthetic testosterone derivative, oxandrolone, promotes weight gain in patients with cancer and HIV, according to the results of two studies presented recently at the American Society for Parenteral and Enteral Nutrition’s 27th Clinical Congress at the 2nd Annual Nutrition Week Scientific Meeting in Aspen, US. In the two open-label studies, 128 HIV positive patients and 139 cancer patients who had been actively losing weight were administered oxandrolone [‘Oxandrin’] 20 mg/day for four months combined with education in nutrition and exercise. The researchers found that approximately 80% of cancer patients were able to gain or maintain weight with an average increase in lean tissue of 4lbs. Similarly, a majority of HIV positive patients maintained their existing weight or gained weight; the average increase among these patents was 6.6lbs, including 4.6lbs of lean tissue. Oxandrolone therapy was also associated with improved scores on assessments of quality of life and activities of daily living. Bio-Technology General Corp.. Weight Gain in Patients With Cancer & HIV - Final Research Presented at ASPEN -. Media Release : 20 Jan 2003. Available from: URL: <a href="http://www.btgc.com" target="_blank">http://www.btgc.com</a> 809017364</p></blockquote><p></p>
[QUOTE="Rock H. Johnson, post: 174155, member: 39049"] ■ The synthetic testosterone derivative, oxandrolone, promotes weight gain in patients with cancer and HIV, according to the results of two studies presented recently at the American Society for Parenteral and Enteral Nutrition’s 27th Clinical Congress at the 2nd Annual Nutrition Week Scientific Meeting in Aspen, US. In the two open-label studies, 128 HIV positive patients and 139 cancer patients who had been actively losing weight were administered oxandrolone [‘Oxandrin’] 20 mg/day for four months combined with education in nutrition and exercise. The researchers found that approximately 80% of cancer patients were able to gain or maintain weight with an average increase in lean tissue of 4lbs. Similarly, a majority of HIV positive patients maintained their existing weight or gained weight; the average increase among these patents was 6.6lbs, including 4.6lbs of lean tissue. Oxandrolone therapy was also associated with improved scores on assessments of quality of life and activities of daily living. Bio-Technology General Corp.. Weight Gain in Patients With Cancer & HIV - Final Research Presented at ASPEN -. Media Release : 20 Jan 2003. Available from: URL: [URL]http://www.btgc.com[/URL] 809017364 [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Oxandrolone with 10mg DHEA at the end: blood tests and my experience
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top